VINBLASTINE SULFATE INJECTION
VINBLASTINE SULFATE INJECTION
Approved
DIN Number
02183056
Drug Class
Human
Market Date
Apr 14, 1998
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02183056
AIG Number0103625001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CA01 VINBLASTINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VINBLASTINE SULFATEActive
Strength: 1 MG / ML
Monograph: VINBLASTINE SULFATE